Minor impact of patient alloantibodies against human platelet antigen (HPA)-15 in the effectiveness of platelet transfusion: A pilot study.
Hiroko InoueRumi SakamotoHiroko NishimiyaHiroe SakamotoShota TerasuRyota AminakaYangsook KohYoshihiro TakiharaFumiya HirayamaAyumu KuroishiPublished in: Transfusion (2020)
The efficacy of HPA-15-incompatible platelet transfusions was not necessarily inferior to that of HPA-15 compatible ones. Although the case number was limited, our results suggest that HPA-15 antibodies do not have a significant impact on the effects of platelet transfusion.